This video discusses the critical issue of cancer treatment heterogeneity, where the same cancer type and stage can present with different markers. This often leads to patients receiving ineffective medications, highlighting a crisis in cancer therapy.

Deeper analysis, using advanced techniques like next generation sequencing, could identify the correct targeted therapy and improve patient outcomes. Understanding what is cancer at the genetic level is crucial for effective care.

🎯 What You’ll Learn in This Episode

• Why cancer treatment may not be one-size-fits-all
• What tumor heterogeneity means
• The role of DNA and RNA testing
• Why immune system considerations matter
• How treatment decisions are made
• What questions to ask your oncologist
• Why deeper data may influence care
• How personalized approaches are evolving

📍 Envita Medical Centers – Scottsdale, AZ
🌐 Learn more: www.envita.com
📞 Speak with a care coordinator: 866-830-4576

“The right questions can help you better understand your treatment options.”

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.

You can read the full peer-reviewed study at:

https://www.scirp.org/journal/paperinformation?paperid=132493

This video discusses the critical role of the immune system in treating solid tumors, suggesting it's a key breakthrough not widely offered to many a cancer patient.

Dr. Dino Prato highlights that the immune system's ability to uniquely target and destroy cancer cells makes it superior to conventional drugs, emphasizing the need for advanced cancer therapy and patient care. We discuss why a precision medicine approach, focusing on immunology, is essential for effective cancer care.

🎯 What You’ll Learn in This Episode

• Why the immune system is important in cancer care
• What immunotherapy does
• Why some tumors evade immune detection
• The role of neoantigens and immune signaling
• How different immune cells interact
• Why responses to immunotherapy vary
• The difference between blood cancers and solid tumors
• How personalized approaches are being explored

📍 Envita Medical Centers – Scottsdale, AZ
🌐 Learn more: www.envita.com
📞 Speak with a care coordinator: 866-830-4576

“The immune system doesn’t just fight cancer — it learns how to find it.”

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.

You can read the full peer-reviewed study at:

https://www.scirp.org/journal/paperinformation?paperid=132493

Many cancer patients feel scared and overwhelmed after appointments, often seeking help online.

This video explores the dangers of misinformation in cancer therapy, highlighting how some advice, while seemingly helpful, can be harmful. It emphasizes the critical need for reliable health advice and comprehensive patient education to ensure proper patient care.

🎯 What You’ll Learn in This Episode

• What tele-oncology is and how it’s used
• Why some programs may lack clinical depth
• The difference between navigation and clinical decision-making
• Why deeper testing may matter in cancer care
• How to evaluate cancer guidance programs
• What “precision oncology” should actually include
• Why monitoring matters beyond imaging
• Questions to ask before trusting a program

📍 Envita Medical Centers – Scottsdale, AZ
🌐 Learn more: www.envita.com
📞 Speak with a care coordinator: 866-830-4576

“Not all guidance is equal — the right questions can protect your care.”

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.

You can read the full peer-reviewed study at:

https://www.scirp.org/journal/paperinformation?paperid=132493